SIMA
SIM Acquisition Corp. I10.57
+0.01+0.09%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
324.15MP/E (TTM)
-Basic EPS (TTM)
-Dividend Yield
0%Recent Filings
8-K
Director resigns for personal reasons
SIM Acquisition Corp. I announced the immediate resignation of director Janine Grasso on September 4, 2025, citing personal reasons with no disagreements over operations or policies. She stepped down from the board and its audit and compensation committees. The company plans to appoint a new independent director to meet Nasdaq standards. This change maintains governance continuity amid its SPAC search.
10-Q
Q2 FY2025 results
SIM Acquisition Corp. I posted a solid Q2 net income of $2.3M, fueled by $2.5M in interest from its Trust Account, while general and administrative costs ticked up to $182K from $13K a year ago—typical for a SPAC hunting deals. For the first half, net income hit $4.5M on $4.9M interest, against $423K in expenses, with diluted EPS at $0.15 for redeemable Class A shares on 23M weighted average shares. Cash outside the Trust dipped to $346K, but the $240M Trust provides ample firepower through July 2026. No debt burdens the balance sheet, just a $11M deferred underwriting fee. Trust intact. Yet mandatory liquidation looms if no deal closes by deadline.
10-Q
Q1 FY2025 results
SIM Acquisition Corp. I swung to a $2.2M net income for Q1 FY2025 ended March 31, 2025, up from a $28K loss a year ago, thanks to $2.5M in interest from its Trust Account while general expenses ticked up 748% to $241K on due diligence hunts. No revenue yet, as this blank-check vehicle eyes healthcare targets for a merger by July 2026. Cash outside the Trust dipped to $512K, but the $238M Trust—bolstered by accretions—keeps liquidity solid with no debt beyond a $11M deferred underwriting tab. No non-GAAP metrics disclosed in the 10-Q. Yet tariffs could crimp target hunts.
10-K
FY2024 results
SIM Acquisition Corp. I, a blank check company targeting healthcare, completed its IPO in July 2024, raising $230 million in gross proceeds now held in trust at $235.3 million as of December 31, 2024, yielding $5.3 million in interest income for the year. With no operations yet, the firm posted net income of $4.7 million, driven by that interest offsetting $576 thousand in formation costs, while maintaining $697 thousand in cash outside trust for due diligence. Q4 saw $2.7 million in interest income against $259 thousand in expenses, signaling steady momentum toward a business combination by July 2026. Liquidity remains solid with no debt, but the 24-month deadline looms. No guidance disclosed. Sponsor conflicts could snag deal flow.
10-Q
Q3 FY2024 results
SIM Acquisition Corp. I, a blank-check company targeting healthcare deals, posted a net income of $2.4M for Q3 2024 ended September 30, driven by $2.6M in interest from its $232.6M trust account, while formation costs hit $270K. No revenue yet, as operations await a business combination by July 2026. Cash outside trust stands at $860K, with $1.1M working capital and no debt beyond $11.0M deferred underwriting fees payable on deal close. The IPO in July raised $230M, fully exercising the over-allotment. Sponsors hold 7.7M founder shares. Yet SPAC rules demand extra disclosures on sponsors and projections.
IPO
Sector
Industry
DMAA
Drugs Made In America Acquisiti
10.36-0.00
IBAC
IB Acquisition Corp.
10.45+0.00
IMAQ
International Media Acquisition
9.72+0.00
MACI
Melar Acquisition Corp. I
10.61+0.00
RIBB
Ribbon Acquisition Corp
10.35+0.01
RTAC
Renatus Tactical Acquisition Co
10.59+0.07
SDHI
Siddhi Acquisition Corp
10.25+0.00
SPKL
Spark I Acquisition Corp.
11.23+0.08
SZZL
Sizzle Acquisition Corp. II
10.17+0.00
YHNA
YHN Acquisition I Limited
10.65+0.00